Bookbot
Este es el que agregas al carrito

A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition

Parámetros

  • 817 páginas
  • 29 horas de lectura

Más información sobre el libro

The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

Compra de libros

A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition, Roland T. Skeel

Idioma
Publicado en
2007
Encuadernación
(Tapa blanda),
Estado del libro
Bueno
Precio
9,99 €

Métodos de pago

Nadie lo ha calificado todavía.

Título
A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition
Idioma
Inglés
Publicado en
2007
Formato
Tapa blanda
Páginas
817
ISBN10
0781765315
ISBN13
9780781765312
Serie
Descripción
The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.